Medication adherence and racial differences in A1C control.
about
Glucose control in diabetes: the impact of racial differences on monitoring and outcomesHealth disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statementSocial determinants of type 2 diabetes and health in the United States.Association of African genetic ancestry with fasting glucose and HbA1c levels in non-diabetic individuals: the Boston Area Community Health (BACH) Prediabetes Study.Using quantile regression to investigate racial disparities in medication non-adherence.Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record.Racial differences in diabetes-related psychosocial factors and glycemic control in patients with type 2 diabetes.Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based StudyAn evaluation of patients' adherence with hypoglycemic medications among Papua New Guineans with type 2 diabetes: influencing factorsRace-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III).Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) studyElevated HbA1c levels in individuals not diagnosed with type 2 diabetes in Qatar: a pilot studyRacial ethnic differences in type 2 diabetes treatment patterns and glycaemic control in the Boston Area Community Health SurveyRace and medication adherence and glycemic control: findings from an operational health information exchangeAssessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes.Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes.Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study.Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c)Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes.Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetesDevelopment of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherenceEthnic differences and socio-demographic predictors of illness perceptions, self-management, and metabolic control of type 2 diabetesDiabetes in African American youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study.Racial disparities in lipid control in patients with diabetes.Using quantile regression to assess disparities in medication adherence.Reducing racial/ethnic disparities in diabetes: the Coached Care (R2D2C2) project.Comorbid depression is differentially associated with longitudinal medication nonadherence by race/ethnicity in patients with type 2 diabetesImpact on glycated haemoglobin of a biological response-based measure of medication adherence.Do race and ethnicity impact hemoglobin A1c independent of glycemia?Patient adherence to medication requirements for therapy of type 2 diabetes.Genetic disparities in the development of type 2 diabetes among African Americans.The association between the measurement of adherence to anti-diabetes medicine and the HbA1c.Medication Adherence With Diabetes Medication: A Systematic Review of the Literature.Self-Care Disparities Among Adults with Type 2 Diabetes in the USA.Longitudinal effects of medication nonadherence on glycemic control.The Aston Medication Adherence Study: mapping the adherence patterns of an inner-city population.Medication adherence and glycemic control among newly diagnosed diabetes patientsEthnic/racial determinants of glycemic markers in a UK sample.Are There Clinical Implications of Racial Differences in HbA1c? Yes, to Not Consider Can Do Great Harm!Understanding Experiences of Diabetes Medications Among African Americans Living With Type 2 Diabetes.
P2860
Q26828633-9AF59E1D-8808-413B-AF59-ED25038D1DD4Q28388174-51713918-E216-4969-9253-18B715F1CE3FQ30412489-7F7275BB-6A00-4ECB-BC1E-D3AE4D874606Q33656987-E9152A73-48E3-4AE3-8E59-1A483C0A9C3CQ33924589-7B7A311B-CB71-4526-9CA1-722CDED11E14Q34129085-8CD24ED0-6A53-4EDF-B154-F14169296297Q34144366-510770AA-CB1C-47C3-AD9A-40ADD97F0C8AQ34189448-81662404-E084-4860-A907-49AF2790D5ACQ34229892-A433985C-9BAC-49FD-82C7-AC410DE45CD3Q34249514-6A4F4464-F2BC-4355-AFED-C951D10ADDB0Q34507025-C875FCA2-0170-4558-B674-C7E869BF0F1EQ35132809-FB89076A-3AB4-4A63-AC79-9A95AB36C6C3Q35604695-A581845A-D427-41EB-9121-C63F8B934449Q35625452-E0D3B3D8-2F25-4563-99B2-61E8ED47E9F2Q35858560-D21F1C4A-2BD9-494B-BCF5-99C99E27DB95Q35869552-40B91B93-7400-4EEA-B7FF-855C9082F59BQ36006414-21CD53B0-2599-49F1-8620-D4201C8ED0CDQ36224463-02F20E3A-70D9-43A0-9044-933C3861A10DQ36595171-DEA488B9-884F-451A-8F51-5DBCD3E20199Q36734095-068F87AE-93A1-4649-ACE2-931FB7D0E99EQ37007304-70C6F773-29A9-4156-9E8E-2BDE3730DABAQ37074887-A6721899-F8CD-427A-9880-6DCBD854647DQ37109425-BB1D572F-3629-4BCF-A9CD-3A2BA3CEE81BQ37154916-C3E0E6F4-E5B9-497F-83FB-2315376AD8A9Q37184314-710A3B93-9610-4A67-93C5-A7CF3C159179Q37203677-7EE9652F-6032-401F-8416-81DA71670C36Q37205215-F8D31846-903E-45A3-BBAD-326A47D48351Q37275626-007782D4-AF57-40B0-9313-4944819403D7Q37404631-4BCAA0D5-9739-4633-8D67-C1253A491A65Q37840269-06EB4080-EB14-415E-ADC6-7C48504B10DAQ37928725-C57DBE36-91E8-45AB-B695-D7D85B4BC904Q38202906-A76A0CD8-BE0C-4A22-91FA-51CF9809CC24Q38659210-E6CD5A96-F57D-42E9-B6E0-54C8B768209FQ38965057-CFA4B44C-90AD-4049-9795-22CBFB45C8F8Q39241507-4CD993C8-00D3-4C1A-A45E-8825E585DC1CQ40154535-EE2D61C6-07F2-47D8-943E-4CEF31549265Q41544336-C000989B-0421-4C25-933C-DFA2C6D49D01Q41624898-6513F97E-5D75-4F1F-B270-CB9A2B908B9FQ42409296-28237BA5-A6F0-463E-B4E6-CAE49BE2E5F8Q46267026-2CC0FCE8-13C2-454C-8235-8D67581FA27D
P2860
Medication adherence and racial differences in A1C control.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Medication adherence and racial differences in A1C control.
@en
type
label
Medication adherence and racial differences in A1C control.
@en
prefLabel
Medication adherence and racial differences in A1C control.
@en
P2093
P2860
P356
P1433
P1476
Medication adherence and racial differences in A1C control.
@en
P2093
Alyce S Adams
Connie Mah Trinacty
Fang Zhang
Ken Kleinman
Richard W Grant
Stephen B Soumerai
P2860
P304
P356
10.2337/DC07-1924
P407
P577
2008-01-30T00:00:00Z